Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case Report
Here, we describe a case of temporary severe neutropenia after atezolizumab monotherapy and its treatment course. Atezolizumab monotherapy was introduced as a 6th-line treatment for a man in his late 60s, who was diagnosed with stage Ⅳ lung adenocarcinoma. The first treatment cycle was administered...
Main Authors: | Ryota Kanno, Yoshitaka Saito, Yoh Takekuma, Hajime Asahina, Mitsuru Sugawara |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-05-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/530338 |
Similar Items
-
A case of urticarial vasculitis associated with atezolizumab
by: Jade N. Young, BS, et al.
Published: (2024-01-01) -
A case of severe acute hemorrhagic duodenitis after administration of immune checkpoint inhibitor
by: Keita Saito, et al.
Published: (2022-04-01) -
A case of perforated immune-related colitis complicated by cytomegalovirus infection during treatment of immune-related adverse effect in lung cancer immunotherapy
by: Masahiro Nakai, et al.
Published: (2023-01-01) -
Atezolizumab‐related sclerosing cholangitis with multiple liver abscesses in a patient with lung squamous cell carcinoma: A case report
by: Daisuke Jingu, et al.
Published: (2024-03-01) -
The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab
by: Katherine E.R. Smith, MD, et al.
Published: (2023-12-01)